Latest News and Press Releases

MECHELEN, Belgium, Feb. 12, 2004 (PRIMEZONE) -- Galapagos Genomics, the Belgian functional genomics company, today announced that it has been awarded by the IWT (The Flemish Institute for the...

MECHELEN, Belgium, Dec. 16, 2003 (PRIMEZONE) -- Galapagos Genomics today announced a target discovery collaboration with Bayer HealthCare AG. Within the partnership, the Companies will collaborate to...

MECHELEN, Belgium, Nov. 13, 2003 (PRIMEZONE) -- Galapagos Genomics today announced that it has entered into a discovery alliance in the field of osteoporosis with Wyeth Pharmaceuticals, the...

MECHELEN, Belgium, Nov. 11, 2003 (PRIMEZONE) -- Boehringer Ingelheim and Galapagos Genomics have entered into a collaboration in the field of antiviral discovery research. Under the terms of this...

MECHELEN, Belgium, Oct. 16, 2003 (PRIMEZONE) -- Galapagos Genomics today announced that it has published its adenoviral siRNA based gene silencing technology in the scientific journal Genome Research...

MECHELEN, Belgium, June 11, 2003 (PRIMEZONE) -- Galapagos Genomics, a privately held functional genomics company, today announced that it has entered into collaboration with Procter & Gamble...

MECHELEN, Belgium, May 13, 2003 (PRIMEZONE) -- Galapagos Genomics, the Netherlands/Belgian functional genomics company, today announced the launch of their human full-length gene adenoviral...

MECHELEN, Belgium, April 29, 2003 (PRIMEZONE) -- Inpharmatica Ltd. a leading informatics-driven drug discovery company, and Galapagos Genomics NV, the Belgian functional genomics company, today...

MECHELEN, Belgium, April 7, 2003 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, and Degussa BioActives announced today that they have entered into a research...

MECHELEN, Belgium, Jan. 16, 2003 (PRIMEZONE) -- Galapagos Genomics, the Belgian functional genomics company, today announced that it has launched its SilenceSelect(TM) gene silencing platform. With...